“Delivering efficiencies to drug discovery has the potential to revolutionise the way early projects are executed, enabling more dynamic target selections from the burgeoning set of opportunitie ...

The pharmaceutical industry faces environmental challenges. Green chemistry offers sustainable solutions to reduce waste and ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger ...

Indiana University School of Medicine scientists have developed a powerful new imaging technique to study bone marrow in ...

The researchers identified the structure of this machine, the mitochondrial pyruvate carrier (MPC), and 50 years since its discovery ... and represents a potential drug target for treating ...

The discovery not only solves a biochemical mystery, but also opens the door to greener, more efficient ways of making pharmaceuticals. The molecule in question is a carbene, a type of carbon atom ...

A recent study published in the Journal of the American Medical Association highlights the potential benefits of integrating yoga and strengthening exercises into OA treatment plans. Over a 24-week ...

From accelerating drug discovery to enabling personalized medicine and uncovering complex disease mechanisms, these advancements are redefining how we understand and treat diseases.

A Repurposed Anti-Inflammatory Drug May Help Treat Alcohol Use Disorder ... and Hair Loss Apr. 18, 2025 — Fifty years since its discovery, scientists have finally worked out how a molecular ...

“Receiving orphan drug designation for TPST-1495, our second clinical program, is a significant milestone in our mission to bring innovative therapies to patients with unmet medical need ...

Artificial intelligence is increasingly becoming a cornerstone in pharmaceutical research, with numerous companies leveraging advanced algorithms to expedite drug discovery and development. This ...

Applied DNA Sciences (APDN) has completed a long-term initiative to source critical input materials for its LineaDNA and LineaIVT platforms from U.S.-based suppliers. The initiative, undertaken in ...